BIOMERICA INC Equity Securities without Readily Determinable Fair Value, Impairment Loss, Cumulative Amount
BIOMERICA INC (BMRA) had Equity Securities without Readily Determinable Fair Value, Impairment Loss, Cumulative Amount of $0 as of 2026-05-31, per its 10-K filed 2026-08-31.
Financial Statements › Notes › Equity Securities without Readily Determinable Fair Value, Impairment Loss, Cumulative Amount
us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossCumulativeAmount · last filed 2026-08-31
- 2026-05-31: Equity Securities without Readily Determinable Fair Value, Impairment Loss, Cumulative Amount $0.00.
| Period end | Equity Securities without Readily Determinable Fair Value, Impairment Loss, Cumulative Amount |
|---|---|
| 2026-05-31 | $0.00 10-K · filed 2026-08-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |